PRA Health Sciences (PRAH) Tops Q3 EPS by 29c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
Go back to PRA Health Sciences (PRAH) Tops Q3 EPS by 29c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
November 5, 2020 12:48 PM EST
Mizuho Securities analyst Ann Hynes raised the price target on PRA Health Sciences (NASDAQ: PRAH) to $110.00 (from $108.00) while maintaining a Neutral rating.
...
More